The inflammatory myopathies are a heterogeneous group of diseases which have been suspected of having an autoimmune basis. Intensive work in the past ten years in our laboratory, as well as others, has revealed the presence of disease specific antibodies which relate certain autoantibodies to specific disease subsets. Thus, antibodies to Jol (histidyl tRNA synthetase) occur principally in polymyositis associated with interstitial lung disease. Antibodies to other translation related proteins (as yet of unidentified function) also seem to be associated with this clinical picture. Antibodies to Mi2, a nuclear antigen of unknown function occur primarily in patients with dermatomyositis while antibodies to Pm- Scl, a nucleolar antigen, occur in patients most frequently with polymyositis-scleroderma overlap. We propose to build on these findings by improving the immunoassays for these serological reactions, determining the molecular structure and function of the antigens, and further determining the clinical diagnostic specificity of these reactions. The relationship of the titer of these antibodies to the severity and activity of the disease will also be studied. In addition, systematic HLA studies will be performed so that genetic factors related to specific autoantibody production can be ascertained. Finally, the hypothesis that infection with picornaviruses may be an important initiating event in these diseases will be explored by determining if 1) autoantibodies to translation related proteins can bind picornaviral RNA in immunoprecipitation studies and conversely if 2) convalescent sera from patients with picornavirus infection can inhibit translation related proteins which are known to be targets of autoimmunity in polymyositis patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR032214-05
Application #
3156232
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1983-04-01
Project End
1993-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Okano, Y; Targoff, I N; Oddis, C V et al. (1996) Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity. Clin Immunol Immunopathol 81:41-7
Ge, Q; Wu, Y; James, J A et al. (1996) Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen. Arthritis Rheum 39:1588-95
Arnett, F C; Targoff, I N; Mimori, T et al. (1996) Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 39:1507-18
Tsuzaka, K; Leu, A K; Frank, M B et al. (1996) Lupus autoantibodies to double-stranded DNA cross-react with ribosomal protein S1. J Immunol 156:1668-75
Friedman, A W; Targoff, I N; Arnett, F C (1996) Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 26:459-67
Nilasena, D S; Trieu, E P; Targoff, I N (1995) Analysis of the Mi-2 autoantigen of dermatomyositis. Arthritis Rheum 38:123-8
Ge, Q; Nilasena, D S; O'Brien, C A et al. (1995) Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest 96:1730-7
Reichlin, M (1995) Cell injury mediated by autoantibodies to intracellular antigens. Clin Immunol Immunopathol 76:215-9
Arnett, F C; Reichlin, M (1995) Lupus hepatitis: an under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med 99:465-72
Koren, E; Koscec, M; Wolfson-Reichlin, M et al. (1995) Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells. J Immunol 154:4857-64

Showing the most recent 10 out of 33 publications